RadioGel® is not FDA-approved for commercial use in the United States.
Revolutionizing Cancer Treatment
The Science Of RadioGel®
Y-90 RadioGel™ is a device designed for radiation treatment of solid tumors. The Y-90 RadioGel™/Hydrogel mixture is injected directly and uniformly into tumors.
IDE Submission
Vivos Inc. Announces Significant Progress Toward FDA Investigational Device Exemption (IDE) Submission for RadioGel® Precision Radionuclide Therapy™
RadioGel is currently not approved for human use in the United States.
Precision Radionuclide Therapy™
Also known as PRnT™, the treatment uses highly localized radiation to destroy cancerous tumors by placing a radioactive isotope directly inside the treatment area, delivering therapeutic radiation from within the tumor.
Meet The Team
We are a team dedicated to developing a safer, less invasive cancer treatment for humans and animals worldwide.
